Accession |
PRJCA017000 |
Title |
A Phase II clinical study to evaluate the clinical efficacy and safety of HLX10 combined with HLX07 in patients with advanced head and neck tumors |
Relevance |
Medical |
Data types |
PK and ADA
|
Organisms |
Homo sapiens
|
Description |
A Phase II clinical study to evaluate the clinical efficacy and safety of HLX10 (recombinant anti-PD-1 humanized monoclonal antibody) combined with HLX07 (recombinant anti-EGFR humanized monoclonal antibody) in patients with advanced head and neck tumors |
Sample scope |
Multiisolate |
Release date |
2023-05-15 |
Grants |
Agency |
program |
Grant ID |
Grant title |
No funding support
|
|
|
|
|
Submitter |
Ye
Guo (pattrickguo@gmail.com)
|
Organization |
Shanghai East Hospital |
Submission date |
2023-05-15 |